Suraj Kalia
Stock Analyst at Oppenheimer
(3.66)
# 829
Out of 4,944 analysts
81
Total ratings
46.38%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRCT PROCEPT BioRobotics | Initiates: Perform | n/a | $40.38 | - | 1 | Jul 7, 2025 | |
| PLSE Pulse Biosciences | Initiates: Outperform | $22 | $16.82 | +30.80% | 1 | Jul 7, 2025 | |
| TMDX TransMedics Group | Maintains: Outperform | $130 → $150 | $132.04 | +13.60% | 11 | Jun 17, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $36.73 | +22.52% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $10.69 | +115.15% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $166.86 | -28.08% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $43.73 | -26.82% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $95.15 | -2.26% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $129.40 | +0.46% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $3.70 | +170.27% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 | $77.68 | +15.86% | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $13 | $6.35 | +104.72% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $109.58 | +23.20% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $288.28 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $12.95 | +131.66% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $320 → $200 | $2.45 | +8,063.27% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $75.33 | +28.77% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.68 | +9.03% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $1.42 | +216.90% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.78 | +798.88% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $482.35 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.44 | +26,949.18% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $87.36 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $4.55 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $24.11 | +314.77% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $79.96 | - | 5 | Sep 12, 2018 |
PROCEPT BioRobotics
Jul 7, 2025
Initiates: Perform
Price Target: n/a
Current: $40.38
Upside: -
Pulse Biosciences
Jul 7, 2025
Initiates: Outperform
Price Target: $22
Current: $16.82
Upside: +30.80%
TransMedics Group
Jun 17, 2025
Maintains: Outperform
Price Target: $130 → $150
Current: $132.04
Upside: +13.60%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $36.73
Upside: +22.52%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $10.69
Upside: +115.15%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $166.86
Upside: -28.08%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $43.73
Upside: -26.82%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $95.15
Upside: -2.26%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $129.40
Upside: +0.46%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $3.70
Upside: +170.27%
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $77.68
Upside: +15.86%
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $6.35
Upside: +104.72%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $109.58
Upside: +23.20%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $288.28
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $12.95
Upside: +131.66%
Jun 23, 2023
Maintains: Outperform
Price Target: $320 → $200
Current: $2.45
Upside: +8,063.27%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $75.33
Upside: +28.77%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $25.68
Upside: +9.03%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $1.42
Upside: +216.90%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $1.78
Upside: +798.88%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $482.35
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.44
Upside: +26,949.18%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $87.36
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $4.55
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $24.11
Upside: +314.77%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $79.96
Upside: -